Algorithm for the selection of endoprosthesis technology in patients with stage IV gonarthrosis, with different degrees of damage to the ligamentous and bone structures of the knee joint

21 серпня 2024
951
УДК:  616.72-002
Спеціальності :
Резюме

Purpose: to develop and evaluate the effectiveness of a differentiated approach to knee arthroplasty in patients with gonarthrosis complicated by bone defects and instability of the ligamentous apparatus.

Object and research methods. A retrospective study of the results of knee arthroplasty in 314 patients with stage IV gonarthrosis according to the Kellgren — Lawrence classification, complicated by bone defects of the femoral and tibial condyles and varying degrees of instability of the ligamentous apparatus, was conducted. A differentiated approach to selecting the type of endoprosthesis and surgical technique was applied depending on the size of the defect and the state of the ligamentous apparatus.

The results. It has been established that in case of condylar defects <5 mm, bone cement replacement with endoprosthesis implantation without preservation of the posterior cruciate ligament is effective. For defects >5 mm, it is optimal to use augments with an endoprosthesis without preserving the posterior cruciate ligament. In cases of combined defects and partial failure of collateral ligaments, the use of endoprostheses of the LCCK type proved to be effective. In the case of significant damage to the ligamentous apparatus, the best results were shown by the use of integral endoprostheses of the Hinge type.

Conclusion. The proposed differentiated approach to knee arthroplasty allows to optimize the surgical treatment of patients with gonarthrosis complicated by bone defects and instability, providing better functional results and reducing the risk of complications. Individualization of the choice of endoprosthesis type and surgical technique is a key factor in the successful treatment of complex forms of gonarthrosis.

References

  • 1. GBD 2021 Osteoarthritis Collaborators (2023) Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 5(9): E508–E522.
  • 2. GBD 2021 Osteoarthritis Collaborators (2023) Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol., 5(9): e508–e522. doi: 10.1016/S2665-9913(23)00163-7.
  • 3. Allen K.D., Thoma L.M., Golightly Y.M. (2022) Epidemiology of osteoarthritis. Osteoarthritis Cartilage, 30(2): 184–195. doi: 10.1016/j.joca.2021.04.020.
  • 4. Giorgino R., Albano D., Fusco S. et al. (2023) Knee Osteoarthritis: Epidemiology, Pathogenesis, and Mesenchymal Stem Cells: What Else Is New? An Update. Int. J. Mol. Sci., 24(7): 6405. doi: 10.3390/ijms24076405.
  • 5. Uivaraseanu B., Vesa C.M., Tit D.M. et al. (2022) Therapeutic approaches in the management of knee osteoarthritis (Review). Exp. Ther. Med., 23(5): 328. doi: 10.3892/etm.2022.11257.
  • 6. Postler A.E., Lützner C., Goronzy J. et al. (2023) When are patients with osteoarthritis referred for surgery? Best Pract. Res. Clin. Rheumatol., 37(2): 101835. doi: 10.1016/j.berh.2023.101835.